The Global Pharmaceutical Contract Manufacturing Market was worth USD 192.65 Billion in 2023. As such, the forecast is that the market is expected to reach USD 443.23 Billion by 2032 with a CAGR of 9.7% from 2024 to 2032. In this setup, pharmaceutical companies partner with external manufacturers to handle various tasks, such as developing formulations, producing drugs, packaging, and...